Immutep (ASX:IMM) reports first subject dosed in autoimmune disease study
19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.
Stocks of the Hour: Euro Manganese, Mithril Resources, Control Bionics
19 Aug 2024 - A snapshot of the stocks on the move, featuring Euro Manganese (ASX:EMN), Mithril Resources (ASX:MTH) and Control Bionics (ASX:CBL).
US stocks end strongest week of 2024
19 Aug 2024 - US shares surged on Friday, capping off their most successful week of 2024 as the market rebounded from a sharp decline earlier in August.
Blue dinosaurs and oat milk: CEO Alex Aleksic discusses Forbidden Foods
15 Aug 2024 - Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.
US stocks grow on strong retail sales data, semiconductors lead
16 Aug 2024 - US stocks surged on Thursday as upbeat consumer and labour data fuelled a rally, easing recession fears and bolstering investor confidence.
